Syphilitic aortic stenosis

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47

Aortic stenosis was significantly associated with increased all-cause mortality in MI patients treated with DAPT, with approximately 2-fold increased risk in Sweden and 1.5-fold in Denmark.

Effect: decline; HR 1.76; CI: 95% CI 1.26-2.47